Advances in Schizophrenia Research 2009

• Corporate Author: SpringerLink (Online service)
• Other Authors: Gattaz, Wagner F. (Editor), Busatto, Geraldo. (Editor)
• Format: Electronic
• Language: English
• Published: New York, NY : Springer New York, 2010.
• Subjects: Medicine.; Neurology.; Psychiatry.; Psychology, clinical.; Consciousness.; Medicine & Public Health.; Personality and Social Psychology.; Neuropsychology.
• Online Access: https://ezaccess.library.uitm.edu.my/login?url=http://dx.doi.org/10.1007/978-1-4419-0913-8

Advances in Schizophrenia Research 2009 Edited by Wagner F. Gattaz and Gerardo Busatto Schizophrenia stands as a major psychiatric mystery: devastating to patients and families, resistant to treatment, burdened by stigma, causes unknown. As interest and research in the disorder continue worldwide, n...

Table of Contents:

• Incidence and outcome of schizophrenia across the globe
• Gene and environment interactions and epigenetics of schizophrenia
• The course and outcome of schizophrenia: are there new trends?- Impact of contextual mechanisms on the incidence of schizophrenia and other psychoses
• Perspectives and conclusions
• Glutamate-dopamine interactions in schizophrenia
• Schizophrenia: Neurodevelopmental, neurodegenerative or both?
• The neuropathology of schizophrenia: novel findings and epigenetic regulation
• Molecular neuroimaging, pathophysiological mechanisms and drug discovery
• Discussant
• Molecular genetics of schizophrenia: new discoveries and controversies
• Genetic and developmental animal models of schizophrenia
• Neuroproteomic studies of post-mortem brains in schizophrenia
• Neuroimaging studies of gene effects in the brain in schizophrenia
• Pharmacogenomics in schizophrenia
• Perspectives and conclusions
• Prediction of psychosis through the prodromal syndrome
• Is schizophrenia a cognitive disorder?- Disorder of social cognition
• Impact of new strategies (early intervention, second-generation drugs) on the course and outcome of schizophrenia
• Perspectives and conclusions
• Dimensional dysfunctions
• Risk factors for psychosis all impact on dopamine
• Cannabis: clue or distraction?
• The totality of psychosis
• Perspectives and conclusionst
• Comparative efficacy and safety of second-generation antipsychotics: facts and fiction
• Neuroreceptors, schizophrenia and antipsychotic action
• Does the use of long-acting antipsychotics impact significantly on the outcome of schizophrenia?- Modern community care strategies for the treatment of schizophrenia and their impact on outcome
• Does Stigma impair treatment response and rehabilitation in schizophrenia?- Perspectives and conclusions.